SCHEMBL6561938

SCHEMBL6561938

Cc1cc(C(=O)N2CCCC2)c(C)cc1C#CCNc1ccc(C(=N)NC(=O)OC(C)(C)C)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.36
RIN1 Q13671 1/20 0.36
CNR2 P34972 1/20 0.35
ACACB O00763 1/20 0.34
F10 P00742 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 2/20 0.33
JAK1 P23458 1/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
MMP2 P08253 3/20 0.33
MMP13 P45452 3/20 0.33
ADAM17 P78536 3/20 0.33
MMP14 P50281 2/20 0.33
ALDH1A1 P00352 1/20 0.33
RAB9A P51151 1/20 0.33
TSHR P16473 1/20 0.33
L3MBTL3 Q96JM7 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
DDB1 Q16531 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6563568 0.90 CNR2 (0.39) ABL1RIN1CNR2GAAHPGD
SCHEMBL6565533 0.88 ACACB (0.45) ABL1RIN1CNR2ACACBF10
SCHEMBL6563627 0.87 PTPN11 (0.33) JAK1DDB1CRBN
SCHEMBL6563752 0.87 GAA (0.35) GAAHPGDMEN1KMT2AALDH1A1
SCHEMBL6565309 0.86 PTPN11 (0.34) DDB1CRBN
SCHEMBL6563741 0.85 AAK1 (0.35)
SCHEMBL6565352 0.84 PTPN11 (0.33)
SCHEMBL6561810 0.84 HSD11B1 (0.40) ABL1RIN1CNR2ACACBF10
SCHEMBL7674981 0.84 ABL1 (0.43) ABL1RIN1CNR2ACACBGAA
SCHEMBL6565278 0.83 PTPN11 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140802-B1 SUBSTITUTED ARYL AND HETEROARYL DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINES BOEHRINGER INGELHEIM PHARMA (DE) 2004-03-17 EP disclosed
US-6479524-B1 TO PROLONG THE THROMBIN TIME BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-11-12 US disclosed